BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2015 2:22:00 PM | Browse: 291 | Download: 463
Publication Name World Journal of Hepatology
Manuscript ID 14190
Country of Manuscript Source South Korea
2014-09-23 18:46
Peer-Review Started
2014-09-23 19:28
To Make the First Decision
2014-11-27 12:18
Return for Revision
2014-12-02 16:11
2015-02-12 17:27
Second Decision
2015-04-09 16:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-04-14 15:59
Articles in Press
2015-04-14 16:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-05-27 15:21
Publish the Manuscript Online
2015-06-16 14:22
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein
Manuscript Source Invited Manuscript
All Author List Su Jong Yu and Yoon Jun Kim
Funding Agency and Grant Number
Correspondence To Yoon Jun Kim, MD, Professor, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea. yoonjun@snu.ac.kr
Keywords Sorafenib; Hepatocellular carcinoma; Portal vein; Thrombosis
Core Tip Given the modest survival gain and the limitation of sorafenib, such as resistance and tolerability, there are still clinical unmet needs in the management of patients with hepatocellular carcinoma (HCC) accom-panying portal vein tumor thrombosis (PVTT). Surgical resection-based multimodal treatments including liver transplantation and transarterial chemoembolization-based appropriate combination strategies for resectable HCC accompanying PVTT may improve overall survival in these patients.
Publish Date 2015-06-16 14:22
Citation Yu SJ, Kim YJ. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World J Hepatol 2015; 7(11): 1553-1561
Url http://www.wjgnet.com/1948-5182/full/v7/i11/1553.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i11.1553
Full Article (PDF) WJH-7-1553.pdf
Full Article (Word) WJH-7-1553.doc
Revised Manuscript 14190-Review.doc
Peer-review Report 14190-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 14190-Journal editor-in-chief review report.pdf
Answering Reviewers 14190-Answering reviewers.pdf
Scientific Misconduct Check 14190-Scientific misconduct check.pdf
Scientific Editor Work List 14190-Scientific editor work list.pdf
Conflict-of-Interest Disclosure Form 14190-Conflict-of-interest statement.pdf
Copyright License Agreement 14190-Copyright assignment.pdf